Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Clinical trial NCT00003451 · COMPLETED

Trial details

NCT number: NCT00003451
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous Condition Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1998-08-01
Primary completion: 2001-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.